Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vela Diagnostics is a global provider of integrated molecular diagnostic solutions that utilize both Next-Generation Sequencing (NGS) and real-time PCR on a common automated platform. The company's proprietary Sentosa system streamlines workflows by providing a seamless transition from sample extraction to result reporting, significantly reducing manual intervention. Their portfolio covers a wide range of clinical applications, including infectious disease monitoring, oncology mutation profiling, and virology. By offering standardized and automated diagnostic tools, Vela Diagnostics enables laboratories to improve efficiency and accuracy in detecting complex genetic markers and pathogens.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on V.E.L.A..